Tirzepatide 20mg

Description

Tirzepatide provides researchers with a mid-scale quantity of this dual-receptor agonist peptide, supporting extended experimental timelines and comprehensive dose-response evaluations in metabolic signaling research.

This format is particularly useful for laboratories conducting receptor pharmacology studies, as it provides sufficient material for concentration-response testing across multiple cell lines, assay platforms, and experimental conditions.

Tirzepatide activates both glucose-dependent insulinotropic polypeptide, commonly known as GIP, and glucagon-like peptide-1, commonly known as GLP-1, receptor pathways through a single molecular structure. This dual-receptor activity makes it a valuable research tool for investigating receptor co-activation, signal transduction, and metabolic pathway integration.

In laboratory settings, Tirzepatide may be studied using cell lines engineered to express recombinant GIP and GLP-1 receptors. Researchers may also use this compound to examine downstream cellular responses associated with dual-receptor activation in pancreatic beta cells, hepatocyte cultures, and other experimental metabolic models.

The molecular structure of Tirzepatide includes a fatty-acid modification designed to extend stability and receptor exposure. This characteristic also makes it useful for research involving lipidated peptide design, peptide-receptor interactions, and extended-action peptide pharmacology.

Each vial from PEPTEX Labs contains research-grade, lyophilized Tirzepatide produced under controlled quality standards and accompanied by supporting quality documentation.

This product is supplied exclusively for laboratory research purposes. It is not intended for human or veterinary use.